Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of fosaprepitant versus aprepitant for prevention of chemotherapy-induced vomiting in children
ChiCTR2000040681Phase 4Completed
- Sponsor
- Shanghai Children's Medical Center
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chemotherapy-induced nausea and vomiting (CINV) comparing Fosaprepitant arm with Aprepitant arm (2 arms). Primary endpoint: Number of vomiting episodes. Started Dec 2020; status: completed.
02
Drugs
fosaprepitantaprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR2000040681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040681.